Goldman Sachs’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Goldman Sachs's ACLS Position: Q2 2026 in Review
Goldman Sachs reduced its Axcelis (ACLS) stake by 53% in Q2 2026, selling an estimated $38.9M and leaving 235,253 shares worth $44.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1911.
Goldman Sachs first reported a position in ACLS in Q2 2013 and has held it in 53 quarters since. The position peaked at $99.9M in Q2 2024. 440 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Goldman Sachs held 235,253 shares of Axcelis worth $44.6M as of Q2 2026.
- Goldman Sachs sold 262,371 Axcelis shares in Q2 2026, an estimated $38.9M.
- Axcelis made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1911 holding.
- Goldman Sachs first reported a position in Axcelis in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Axcelis position peaked at $99.9M in Q2 2024.
- 440 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.